F. O. Walker, Huntington's disease, The Lancet, vol.369, issue.9557, pp.218-228, 2007.
DOI : 10.1016/S0140-6736(07)60111-1

R. A. Roos, Huntington's disease: a clinical review, Orphanet Journal of Rare Diseases, vol.5, issue.1, p.40, 2010.
DOI : 10.1186/1750-1172-5-40

E. Roze, S. Betuing, C. Deyts, M. Vidailhet, and J. Caboche, Physiopathologie de la maladie de Huntington??: ??tat des connaissances, Revue Neurologique, vol.164, issue.12, pp.977-994, 2008.
DOI : 10.1016/j.neurol.2008.03.006

T. Vinther-jensen, A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington???s disease, Orphanet Journal of Rare Diseases, vol.74, issue.1, p.114, 2014.
DOI : 10.1186/s13023-014-0114-8

J. S. Paulsen, Detection of Huntington's disease decades before diagnosis: the Predict-HD study, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.8, pp.874-880, 2008.
DOI : 10.1136/jnnp.2007.128728

S. J. Tabrizi, Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data, The Lancet Neurology, vol.8, issue.9, pp.791-801, 2009.
DOI : 10.1016/S1474-4422(09)70170-X

E. H. Aylward, Onset and rate of striatal atrophy in preclinical Huntington disease, Neurology, vol.63, issue.1, pp.66-72, 2004.
DOI : 10.1212/01.WNL.0000132965.14653.D1

K. Duff, Mild cognitive impairment in prediagnosed Huntington disease, Neurology, vol.75, issue.6, pp.500-507, 2010.
DOI : 10.1212/WNL.0b013e3181eccfa2

R. Reilmann, B. R. Leavitt, and C. A. Ross, Diagnostic criteria for Huntington's disease based on natural history, Movement Disorders, vol.29, issue.11, pp.1335-1341, 2014.
DOI : 10.1002/mds.26011

T. M. Blekher, Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington???s disease, Vision Research, vol.44, issue.23, pp.2729-2736, 2004.
DOI : 10.1016/j.visres.2004.06.006

M. Orth, Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.12, p.1184, 2010.
DOI : 10.1136/jnnp.2010.209668

S. C. Kirkwood, J. L. Su, P. Conneally, and T. Foroud, Progression of Symptoms in the Early and Middle Stages of Huntington Disease, Archives of Neurology, vol.58, issue.2, pp.273-278, 2001.
DOI : 10.1001/archneur.58.2.273

G. M. Peavy, Cognitive and functional decline in Huntington's disease: Dementia criteria revisited, Movement Disorders, vol.71, issue.9, pp.1163-1169, 2010.
DOI : 10.1002/mds.22953

J. S. Paulsen, Cognitive Impairment in Huntington Disease: Diagnosis and Treatment, Current Neurology and Neuroscience Reports, vol.75, issue.1, pp.474-483, 2011.
DOI : 10.1007/s11910-011-0215-x

A. Montoya, Episodic memory impairment in Huntington's disease: A meta-analysis, Neuropsychologia, vol.44, issue.10, pp.1984-1994, 2006.
DOI : 10.1016/j.neuropsychologia.2006.01.015

E. Mccusker and C. Loy, The many facets of unawareness in huntington disease, Tremor Hyperkinetic Mov. N. Y. N, vol.4, p.257, 2014.

E. Van-duijn, E. M. Kingma, and R. C. Van-der-mast, Psychopathology in Verified Huntington???s Disease Gene Carriers, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.19, issue.4, pp.441-448, 2007.
DOI : 10.1176/jnp.2007.19.4.441

A. A. Hubers, Suicidal ideation in a European Huntington's disease population, Journal of Affective Disorders, vol.151, issue.1
DOI : 10.1016/j.jad.2013.06.001

M. Dale and E. Van-duijn, Anxiety in Huntington???s Disease, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.27, issue.4
DOI : 10.1176/appi.neuropsych.14100265

E. Van-duijn, Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY), Journal of Neurology, Neurosurgery & Psychiatry, vol.64, issue.12, pp.1411-1418, 2014.
DOI : 10.1136/jnnp-2013-307343

N. A. Aziz, Weight loss in Huntington disease increases with higher CAG repeat number, Neurology, vol.71, issue.19, pp.1506-1513, 2008.
DOI : 10.1212/01.wnl.0000334276.09729.0e

L. Djoussé, Weight loss in early stage of Huntington's disease, Neurology, vol.59, issue.9, pp.1325-1330, 2002.
DOI : 10.1212/01.WNL.0000031791.10922.CF

R. H. Myers, Factors Associated With Slow Progression in Huntington's Disease, Archives of Neurology, vol.48, issue.8, pp.800-804, 1991.
DOI : 10.1001/archneur.1991.00530200036015

N. Saleh, Neuroendocrine Disturbances in Huntington's Disease, PLoS ONE, vol.156, issue.3, p.4962, 2009.
DOI : 10.1371/journal.pone.0004962.t004

P. Ribaï, Psychiatric and Cognitive Difficulties as Indicators of Juvenile Huntington Disease Onset in 29 Patients, Archives of Neurology, vol.64, issue.6, pp.813-819, 2007.
DOI : 10.1001/archneur.64.6.813

O. W. Quarrell, Managing juvenile Huntington???s disease, Neurodegenerative Disease Management, vol.3, issue.3, 2013.
DOI : 10.2217/nmt.13.18

P. Gonzalez-alegre and A. Afifi, Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature, J. Child Neurol, vol.21, pp.223-229, 2006.

G. Nicolas, Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume, American Journal of Medical Genetics Part A, vol.67, issue.4, pp.815-818, 2011.
DOI : 10.1002/ajmg.a.33911

R. H. Myers, Late onset of Huntington's disease., Journal of Neurology, Neurosurgery & Psychiatry, vol.48, issue.6, pp.530-534, 1985.
DOI : 10.1136/jnnp.48.6.530

B. Kremer, Molecular analysis of late onset Huntington's disease., Journal of Medical Genetics, vol.30, issue.12, pp.991-995, 1993.
DOI : 10.1136/jmg.30.12.991

C. M. James, G. D. Houlihan, R. G. Snell, J. P. Cheadle, and P. S. Harper, Late-onset Huntington's Disease: A Clinical and Molecular Study, Age and Ageing, vol.23, issue.6, pp.445-448, 1994.
DOI : 10.1093/ageing/23.6.445

H. Lipe and T. Bird, Late onset Huntington Disease: Clinical and genetic characteristics of 34 cases, Journal of the Neurological Sciences, vol.276, issue.1-2, pp.159-162, 2009.
DOI : 10.1016/j.jns.2008.09.029

G. Koutsis, G. Karadima, A. Kladi, and M. Panas, Late-onset Huntington's disease: Diagnostic and prognostic considerations, Parkinsonism & Related Disorders, vol.20, issue.7, pp.726-730, 2014.
DOI : 10.1016/j.parkreldis.2014.03.017

J. F. Gusella, A polymorphic DNA marker genetically linked to Huntington's disease, Nature, vol.76, issue.5940, pp.234-238, 1983.
DOI : 10.1016/0378-1119(79)90051-9

A. Reiner, I. Dragatsis, and P. Dietrich, Genetics and Neuropathology of Huntington's Disease, Int. Rev. Neurobiol, vol.98, pp.325-372, 2011.
DOI : 10.1016/B978-0-12-381328-2.00014-6

A. Semaka, CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease, Journal of Medical Genetics, vol.84, issue.10, pp.696-703, 2013.
DOI : 10.1136/jmedgenet-2013-101796

J. Andrich, Huntington's disease as caused by 34 CAG repeats, Movement Disorders, vol.44, issue.6, pp.879-881, 2008.
DOI : 10.1002/mds.21958

C. Kenney, S. Powell, and J. Jankovic, Autopsy-proven Huntington's disease with 29 trinucleotide repeats, Movement Disorders, vol.76, issue.1, pp.127-130, 2007.
DOI : 10.1002/mds.21195

A. Rosenblatt, The association of CAG repeat length with clinical progression in Huntington disease, Neurology, vol.66, issue.7, pp.1016-1020, 2006.
DOI : 10.1212/01.wnl.0000204230.16619.d9

L. Djoussé, Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease, American Journal of Medical Genetics Part A, vol.2, issue.3, pp.279-282, 2003.
DOI : 10.1002/ajmg.a.20190

J. Lee, CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion, Neurology, vol.78, issue.10, pp.690-695, 2012.
DOI : 10.1212/WNL.0b013e318249f683

J. Klempí?, The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease, Movement Disorders, vol.27, issue.1, pp.125-129, 2011.
DOI : 10.1002/mds.23436

J. Li, A Genome Scan for Modifiers of Age at Onset in Huntington Disease: The HD MAPS Study, The American Journal of Human Genetics, vol.73, issue.3, pp.682-687, 2003.
DOI : 10.1086/378133

M. E. Macdonald, Evidence for the GluR6 gene associated with younger onset age of Huntington's disease, Neurology, vol.53, issue.6, pp.1330-1332, 1999.
DOI : 10.1212/WNL.53.6.1330

D. C. Rubinsztein, Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease, Proceedings of the National Academy of Sciences, vol.94, issue.8, pp.3872-3876, 1997.
DOI : 10.1073/pnas.94.8.3872

S. Metzger, Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease, Human Molecular Genetics, vol.17, issue.8, pp.1137-1146, 2008.
DOI : 10.1093/hmg/ddn003

F. Squitieri, L. Frati, A. Ciarmiello, S. Lastoria, and O. Quarrell, Juvenile Huntington's disease: Does a dosage-effect pathogenic mechanism differ from the classical adult disease?, Mechanisms of Ageing and Development, vol.127, issue.2, pp.208-212, 2006.
DOI : 10.1016/j.mad.2005.09.012

A. Michalik and C. Van-broeckhoven, Pathogenesis of polyglutamine disorders: aggregation revisited, Human Molecular Genetics, vol.12, issue.suppl 2, pp.173-186, 2003.
DOI : 10.1093/hmg/ddg295

C. A. Gutekunst, Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology, J. Neurosci. Off. J. Soc. Neurosci, vol.19, pp.2522-2534, 1999.

D. Martindale, Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates, Nature Genetics, vol.51, issue.2, pp.150-154, 1998.
DOI : 10.1016/0014-5793(94)00415-3

F. Saudou, S. Finkbeiner, D. Devys, and M. E. Greenberg, Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions, Cell, vol.95, issue.1, pp.55-66, 1998.
DOI : 10.1016/S0092-8674(00)81782-1

P. Harjes and E. E. Wanker, The hunt for huntingtin function: interaction partners tell many different stories, Trends in Biochemical Sciences, vol.28, issue.8, pp.425-433, 2003.
DOI : 10.1016/S0968-0004(03)00168-3

S. Li and X. Li, Huntingtin???protein interactions and the pathogenesis of Huntington's disease, Trends in Genetics, vol.20, issue.3, pp.146-154, 2004.
DOI : 10.1016/j.tig.2004.01.008

C. Zuccato, Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease, Science, vol.293, issue.5529, pp.493-498, 2001.
DOI : 10.1126/science.1059581

J. P. Vonsattel, Neuropathological Classification of Huntington??s Disease, Journal of Neuropathology and Experimental Neurology, vol.44, issue.6, pp.559-577, 1985.
DOI : 10.1097/00005072-198511000-00003

J. P. Vonsattel, Huntington disease models and human neuropathology: similarities and differences, Acta Neuropathologica, vol.31, issue.1, pp.55-69, 2008.
DOI : 10.1007/s00401-007-0306-6

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847401

T. Stober, W. Wussow, and K. Schimrigk, Bicaudate diameter?the most specific and simple CT parameter in the diagnosis of Huntington's disease, Neuroradiology, vol.28, issue.1, pp.25-28, 1984.
DOI : 10.1007/BF00328198

J. S. Paulsen, fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease, AJNR Am. J. Neuroradiol, vol.25, pp.1715-1721, 2004.

H. D. Rosas, Striatal volume loss in HD as measured by MRI and the influence of CAG repeat, Neurology, vol.57, issue.6, pp.1025-1028, 2001.
DOI : 10.1212/WNL.57.6.1025

S. M. De-la-monte, J. P. Vonsattel, and E. P. Richardson, Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease, Journal of Neuropathology & Experimental Neurology, vol.47, issue.5, pp.516-525, 1988.
DOI : 10.1097/00005072-198809000-00003

R. Ahmad, PET imaging shows loss of striatal PDE10A in patients with Huntington disease, Neurology, vol.82, issue.3, pp.279-281, 2014.
DOI : 10.1212/WNL.0000000000000037

H. Study and G. , Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial, Neurology, vol.66, pp.366-372, 2006.

A. Videnovic, Treatment of Huntington Disease, Current Treatment Options in Neurology, vol.56, issue.2, pp.424-438, 2013.
DOI : 10.1007/s11940-013-0219-8

J. J. Vattakatuchery and R. Kurien, Acetyl Cholinesterase inhibitors in cognitive impairment in Huntington???s disease: A brief review, World Journal of Psychiatry, vol.3, issue.3, pp.62-64, 2013.
DOI : 10.5498/wjp.v3.i3.62

K. M. Shannon and A. Fraint, Therapeutic advances in Huntington's Disease, Movement Disorders, vol.69, issue.11, 2015.
DOI : 10.1002/mds.26331

H. Study and G. , A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease, Neurology, vol.57, pp.397-404, 2001.

G. B. Landwehrmeyer, Riluzole in Huntington's disease: a 3-year, randomized controlled study, Annals of Neurology, vol.57, issue.3, pp.262-272, 2007.
DOI : 10.1002/ana.21181

E. A. Spiegel and H. Wycis, Thalamotomy and pallidotomy for treatment of choreic movements, Acta Neurochirurgica, vol.74, issue.3-4, pp.417-422, 1952.
DOI : 10.1007/BF01405833

V. Gonzalez, Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study, Journal of Neurosurgery, vol.121, issue.1, pp.114-122, 2014.
DOI : 10.3171/2014.2.JNS131722

A. L. Kendall, P. Hantraye, and S. Palfi, Chapter 17 Striatal tissue transplantation in non-human primates, Prog. Brain Res, vol.127, pp.381-404, 2000.
DOI : 10.1016/S0079-6123(00)27018-0

S. B. Dunnett, O. Isacson, D. J. Sirinathsinghji, D. J. Clarke, and A. Björklund, Striatal grafts in rats with unilateral neostriatal lesions???III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching, Neuroscience, vol.24, issue.3, pp.813-820, 1988.
DOI : 10.1016/0306-4522(88)90069-3

A. C. Bachoud-lévi, Motor and cognitive improvements in patients with Huntington's disease after neural transplantation, The Lancet, vol.356, issue.9246, pp.1975-1979, 2000.
DOI : 10.1016/S0140-6736(00)03310-9

A. Bachoud-lévi, Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study, The Lancet Neurology, vol.5, issue.4, pp.303-309, 2006.
DOI : 10.1016/S1474-4422(06)70381-7

M. Paganini, Fetal striatal grafting slows motor and cognitive decline of Huntington's disease, Journal of Neurology, Neurosurgery & Psychiatry, vol.47, issue.9, pp.974-981, 2014.
DOI : 10.1136/jnnp-2013-306533

F. Cicchetti, Mutant huntingtin is present in neuronal grafts in huntington disease patients, Annals of Neurology, vol.68, issue.1, pp.31-42, 2014.
DOI : 10.1002/ana.24174

M. Orth, Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.12, pp.1409-1412, 2011.
DOI : 10.1136/jnnp.2010.209668

Y. A. Grimbergen, Falls and gait disturbances in Huntington's disease, Movement Disorders, vol.248, issue.7, pp.970-976, 2008.
DOI : 10.1002/mds.22003

K. A. Jellinger, Alzheimer-type lesions in Huntington's disease, Journal of Neural Transmission, vol.105, issue.8-9, pp.787-799, 1996.
DOI : 10.1007/s007020050095

M. Y. Davis, C. D. Keene, S. Jayadev, and T. Bird, The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects, J. Huntingt. Dis, vol.3, pp.209-217, 2014.

K. Bürger, R. Mergner, V. Arbusow, F. Padberg, and H. Hampel, Chorea Huntington mit sp??ter Manifestation als Differenzialdiagnose der Alzheimer-Krankheit, Der Nervenarzt, vol.73, issue.9, pp.870-873, 2002.
DOI : 10.1007/s00115-002-1361-9